Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Medicinal Chemistry|April 14, 2006
Bile acid reabsorption inhibitors (BARI): novel hypolipidemic drugsWerner Kramer, Heiner GlombikJournal of Labelled Compounds & Radiopharmaceuticals|July 8, 2020
The magic of small structure differences in a sodium-glucose cotransporter drug discovery project-14 C-labelled drug candidates in a key-differentiating studyManfred Schudok, Heiner Glombik, Volker DerdauDrug Discovery Today. Technologies|December 14, 2017
The Keap1-Nrf2 protein-protein interaction: A suitable target for small moleculesDieter Schmoll, Christian K Engel, Heiner GlombikArzneimittel-Forschung|January 14, 2009
Effects of AVE2268, a substituted glycopyranoside, on urinary glucose excretion and blood glucose in mice and ratsMartin Bickel, Harm Brummerhop, Wendelin Frick, et al.Acta Pharmacologica Sinica|January 4, 2012
AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic ratsHans Ludwig Schäfer, Wolfgang Linz, Eugen Falk, et al.Biomaterials|October 17, 2015
Multivalent glibenclamide to generate islet specific imaging probesAndrej Babič, Smaragda Lamprianou, Laurent Vinet, et al.The Journal of Biological Chemistry|October 14, 2015
Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 SignalingAngelika F Winkel, Christian K Engel, Daniel Margerie, et al.Hepatology Communications|July 7, 2020
Activation of Adenosine Monophosphate-Activated Protein Kinase Reduces the Onset of Diet-Induced Hepatocellular Carcinoma in MiceDieter Schmoll, Nicole Ziegler, Benoit Viollet, et al.Pageof 1